Posted in | News | Minerals

Eastman Chemicals Signs Agreement to License Reduced Sulfur Start-Up Technology to Hydrogen Energy

Hydrogen Energy International LLC and Eastman Chemical Company today announced they have signed a definitive agreement for Eastman to license to HEI its proprietary Reduced Sulfur Start-Up Technology.

This patented technology allows for the operational startup of gasification reactors using a sulfur-free fuel to mitigate a source of sulfur emission during startup events.

Jonathan Briggs, regional director, of Hydrogen Energy said he considers this a significant step for his company in North America. "This license agreement grants us access to technology which will minimize sulfur emissions during start-up of our first solid-fueled gasification facility with carbon-capture," Briggs said.

“Eastman has developed a patented process that essentially eliminates sulfur emissions during start-ups of gasification plants using coal, oil, petroleum coke or other sulfur containing feedstocks,” said Eastman’s Brenda Barnicki, vice president of business development. “This agreement leverages our proprietary technology and know-how which Eastman has obtained from 25 years of experience in coal gasification, and which has resulted in our recognition as the leader in gasification operational excellence”

The licensing agreement is part of Hydrogen Energy’s plan to develop a commercial project in California that generates low carbon hydrogen power from an integrated gasification combined cycle (IGCC) system with carbon capture and storage. Terms of the agreements were not disclosed.
 

For more information on hydrogen energy, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.